UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

~~Pursuant~~PURSUANT toTO ~~Section~~SECTION 13 OR 15 (dD) ofOF ~~the Securities Exchange Act of 1934~~THE

~~Date~~SECURITIES ofEXCHANGE ~~Report~~ACT ~~(Date~~OF ~~of earliest event reported): October 6, 2015~~1934

~~NUTRANOMICS,~~Date ~~INC.~~of Report (~~Exact~~Date ~~name~~ of ~~registrant~~earliest asevent ~~specified~~reported): November in24, ~~its charter)~~2015

Nevada		000-53551		98-0603540
(state or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification Number)

NUTRANOMICS, INC.

11487 South 700 East Salt Lake City, Utah		84020
(address of principal executive offices)		(zip code)

(Exact name of registrant as specified in its charter)

~~(801) 576-8350 (registrant’s telephone number, including area code)~~Nevada

~~Not Applicable~~ (~~former~~State ~~name~~ or ~~former~~Other ~~address,~~Jurisdiction ifof ~~changed since last report~~Incorporation)

000-53551	98-0603540
(Commission File Number)	(IRS Employer Identification No.)

11487 South 700 East, Salt Lake City, UT	84020
(Address of Principal Executive Offices)	(Zip Code)

(801) 576-8350

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Item~~[ ~~3.02 Unregistered~~] Soliciting ~~Sales~~material ofpursuant ~~Equity~~to ~~Securities~~Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

On[ ~~October~~] Pre-commencement ~~15,~~communications 2015, the Company issued 1,000,000 shares of the Company’s Series A Preferred Stock to Zen Family LP, an entity controlled by the Company’s director, Dr. Tracy Gibbs, in consideration of Zen Family LP’s cancellation of 1,000,000 shares of common stock. The securities issued were issued pursuant to ~~exemptions~~Rule ~~from registration requirements relying on Section 4~~14d-2(ab)~~(2)~~ ofunder the ~~Securities~~Exchange Act of(17 ~~1933~~CFR ~~and upon Rule 506 of Regulation D of the Securities Act of 1933, as there was no general solicitation, and the transactions did not involve a public offering~~240.14d-2(b))

~~Item~~[ ~~5.03 Amendments~~] Pre-commencement communications pursuant to ~~Articles~~Rule of13e-4(c) ~~Incorporation~~under orthe ~~Bylaws;~~Exchange ~~Change~~Act in(17 ~~Fiscal~~CFR ~~Year~~240.13e-4(c))

OnItem ~~October~~5.02 Departure ~~6, 2015, the Company filed a Certificate~~ of ~~Amendment~~Directors toor ~~its~~Principal ~~Articles~~Officers; ofElection ~~Incorporation to authorize the issuance~~ of ~~25,000,000 shares of “blank-check” preferred stock, meaning that the Board of~~ Directors; ~~has~~Appointment ~~the authority to determine the rights, preferences and limitations associated with the preferred stock, without having to seek a vote~~ of ~~the~~Principal ~~shareholders of the Company~~Officers. Immediately thereafter on October 6, 2015, the Company filed a Certificate of Designation to designate a series of preferred stock, the Series A Preferred Stock. One million (1,000,000) shares of preferred stock were designated as Series A Preferred Stock. Each share of Series A Preferred Stock entitles the holder to 10,000 votes on all matters submitted to a vote of the Company’s stockholders and is convertible at the election of the holder into one share of common stock. The descriptions of the Certificate of Amendment and Certificate of Designation are qualified in their entirety by the full text of those Certificates, filed as Exhibits 3.1 and 3.2 hereto, and incorporated by reference in this report.

~~Item~~On 9November 24, 2015, Edward J.01 Eyring, II, M.D. resigned as Chief Executive Officer, Chief Financial ~~Statements~~Officer, and ~~Exhibits~~Secretary of Nutranomics, Inc. (the “Company”), and on December 3, 2015, Tracy Gibbs was appointed as Interim Chief Executive Officer, Chief Financial Officer, and Secretary of the Company. Dr. Eyring will remain General Manager overseeing Company operations.

~~The~~Tracy ~~exhibits~~Gibbs ~~listed~~is incurrently the ~~following~~Company’s ~~Exhibit~~chief ~~Index~~science ~~are~~officer ~~filed~~and formulator of its products, and is a director. From September 19, 2013, through September 23, 2014, he was also its President, CEO, CFO, and Secretary. Prior to September 19, 2013, when the Company acquired its wholly owned subsidiary, Health Education Corporation, he was the CEO and founder of Health Education Corporation dba NutraNomics. From 2009 to 2011, Dr. Gibbs took a leave of absence and was hired as ~~part~~the VP of ~~this~~Asia ~~report:~~Operations for Atrium Innovations, a publicly traded holding company based in Quebec, Canada, for several dietary supplement manufacturers and brands including Douglas Labs, Garden of Life, Pure Encapsulations, Mucos Pharma in Germany and others.

3.1 Certificate of Amendment

3.2 Certificate of Designation of Series A Preferred Stock

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the ~~registrant~~Registrant has duly caused this report to be signed on its behalf by the undersigned ~~hereunto~~thereunto duly authorized.

Date: October 27, 2015		NUTRANOMICS, INC.
		By: /s/ Edward J. Eyring, II
		Edward J. Eyring, II
		Chief Executive Officer

Date: December 10, 2015

	NUTRANOMICS, INC.

	By:	/s/ Tracy Gibbs
		Tracy Gibbs

Filing Compare · NUTRANOMICS, INC.